133 related articles for article (PubMed ID: 1169816)
1. Role of BCG immunotherapy in malignant disease.
Hersh EM; Gutterman JU; Mavligit GM; Reed RC
South Med J; 1975 Jun; 68(6):673-5. PubMed ID: 1169816
[No Abstract] [Full Text] [Related]
2. BCG in tumor immunotherapy.
Baldwin RW; Pimm MV
Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
[No Abstract] [Full Text] [Related]
3. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)].
Ogura T
Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203
[No Abstract] [Full Text] [Related]
4. Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines.
Hanna MG; Peters LC; Hoover HC
Prog Clin Biol Res; 1989; 310():51-65. PubMed ID: 2672023
[No Abstract] [Full Text] [Related]
5. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
6. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.
Schwarz MA; Gutterman JU; Hersh EM; Richman SP; Mavligit GM
World J Surg; 1977 Sep; 1(5):555-83. PubMed ID: 272083
[No Abstract] [Full Text] [Related]
7. Immunotherapy of cancer: theory and practice.
Rapp HJ
Proc Inst Med Chic; 1975; 30(8):251-5, 274. PubMed ID: 1103122
[No Abstract] [Full Text] [Related]
8. Nonspecific immunotherapy of malignant tumors.
Milas L; Withers HR
Radiology; 1976 Jan; 118(1):211-8. PubMed ID: 1105663
[TBL] [Abstract][Full Text] [Related]
9. Active immunotherapy against cancer: present status.
Morton DL
Semin Oncol; 1986 Jun; 13(2):180-5. PubMed ID: 3520826
[No Abstract] [Full Text] [Related]
10. BCG and cancer (first of two parts).
Bast RC; Zbar B; Borsos T; Rapp HJ
N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
[No Abstract] [Full Text] [Related]
11. Immunotherapy for malignant disease.
Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519
[No Abstract] [Full Text] [Related]
12. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
13. [Immunotherapy of cancer with BCG].
Yamamura Y; Azuma I
Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604
[No Abstract] [Full Text] [Related]
14. Cancer immunotherapy.
Richman SP; Gutterman JU; Hersh EM
Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776
[TBL] [Abstract][Full Text] [Related]
15. Experimental and clinical evaluation of cancer immunotherapeutics.
Azuma I; Sakurai Y
Cancer Treat Rev; 1981 Sep; 8(3):191-5. PubMed ID: 7030486
[No Abstract] [Full Text] [Related]
16. Inconsistent response of B16 melanoma to BCG immunotherapy.
Kreider JW; Bartlett GL; Purnell DM
J Natl Cancer Inst; 1976 Apr; 56(4):803-10. PubMed ID: 1255799
[TBL] [Abstract][Full Text] [Related]
17. Immunological adjuvants in cancer immunotherapy.
Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
[No Abstract] [Full Text] [Related]
18. Future prospects for immunotherapy.
Rosenberg SA
Cancer; 1975 Aug; 36(2):821-4. PubMed ID: 168962
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
20. Immunotherapy of malignant disease (Part 2).
MacGregor AB; Falk RE
J R Coll Surg Edinb; 1976 Jan; 21(1):43-9. PubMed ID: 765453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
